| Maximal oxygen uptake: VO₂max | VO2max was 55.8 versus 53.7 mL/kg/min in a small study. Product identity and reproducibility have not been established. | 1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedApplying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗ | 12 men who were long-distance runners (crossover study) | - Applying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗
|
|---|
| Peak oxygen uptake: VO₂peak | The study in cyclists found no significant benefit for this outcome. | 2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedCordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗ | 22 men who were competitive cyclists | - Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗
|
|---|
| Cycling time trial | The study in cyclists found no significant benefit for this outcome. | 2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedCordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗ | 22 men who were competitive cyclists | - Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗
|
|---|
| Endurance measures and overall between-group test | The overall multivariate test found no difference between groups. Isolated within-group changes in thresholds do not establish an advantage. | 2/4 LowThe risk of bias assessment notes limitations related to blinding, attrition, or verification of the original study plan. Heterogeneity cannot be assessed from a single study. With no additional grounds for downgrading, confidence was not further downgraded for inconsistency. The assessment applies only to the population, product, and outcome studied. Confidence was not further downgraded on applicability grounds. A small sample, an unavailable confidence interval, or both limit the precision of the estimate. Confidence was not further downgraded for possible publication bias because there were no specific grounds for doing so, although unpublished results cannot be ruled out. | 11 publication describedEffect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial ↗ | 20 healthy people aged 50–75 enrolled, and 15 completed the study | - Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial ↗
|
|---|
| Mean power output, main effect of supplementation | The authors reported a main effect of supplementation on mean power output during repeated sprints (p = 0.01). No statistically significant interaction between conditions was detected.The authors reported a main effect of supplementation on mean power output during repeated sprints (p=0.01). No statistically significant interaction between conditions was detected. | 1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedEffect of Cordyceps Sinensis on repeated-sprint performance following repeated-sprint training in hypoxia in female soccer players ↗ | 39 female soccer players in four training groups | - Effect of Cordyceps Sinensis on repeated-sprint performance following repeated-sprint training in hypoxia in female soccer players ↗
|
|---|
| Change in mean power output | In the hypoxic groups, mean power output changed from 3.65 to 4.77 W/kg versus 3.85 to 4.52 W/kg. The interaction between conditions was not statistically significant. | 1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedEffect of Cordyceps Sinensis on repeated-sprint performance following repeated-sprint training in hypoxia in female soccer players ↗ | 22 female soccer players in the reduced-oxygen training groups | - Effect of Cordyceps Sinensis on repeated-sprint performance following repeated-sprint training in hypoxia in female soccer players ↗
|
|---|
| Sleep quality measured with the PSQI questionnaire | Over four weeks, the sleep questionnaire score fell by 6.45 points with the fermentation beverage and by 1.00 point with placebo. Lower scores indicate better self-rated sleep. | 2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedEffectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool ↗ | 90 adults with primary insomnia were randomized, and 44 in each group completed the study | - Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool ↗
|
|---|
| Severity of long COVID symptoms | At 12 weeks, the symptom score was 8.7 points lower (95% CI −12.7 to −4.8) after adjusting for time since the last infection. Participants knew whether they were receiving the capsules, which may have influenced their responses. | 1/4 Very lowRisk of bias: The open-label comparison and subjective outcomes create a high risk that expectations influenced the results. Consistency across studies: Heterogeneity cannot be assessed from a single study, and there are no additional grounds for downgrading. Confidence was not further downgraded on this basis. Applicability to the specified group: The assessment applies only to the population, product, and outcome studied. Confidence was not further downgraded on this basis. Precision of the estimate: A small sample and/or an unavailable confidence interval limit precision. Possible publication bias: There are no specific grounds for an additional downgrade, although unpublished results cannot be ruled out. Confidence was not further downgraded on this basis. | 11 publication describedRandomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong ↗ | 110 adults with persistent COVID symptoms were randomized, and 100 completed the trial | - Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong ↗
|
|---|
| Fatigue measured by questionnaire | At 12 weeks, the Brief Fatigue Inventory (BFI) score was 8.1 points lower (95% CI −14.2 to −2.0). Participants knew whether they were receiving the capsules, which may have influenced their responses. | 1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis. | 11 publication describedRandomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong ↗ | 110 adults with persistent COVID symptoms were randomized, and 100 completed the trial | - Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong ↗
|
|---|